Skip to main content
. Author manuscript; available in PMC: 2021 Jan 12.
Published in final edited form as: J Allergy Clin Immunol. 2017 Jun 7;141(2):704–717.e5. doi: 10.1016/j.jaci.2017.03.049

TABLE E1.

Posttransplantation complications in patients with GOF-STAT1 mutations

Day after transplantation Reversible Fatal

Patient 1
 Infection
  EBV reactivation + 159 Yes No
  Recurrent pneumonia + 1464 Yes No
 Bleeding (coagulopathy associated with colitis) +2765 Yes No
 CV
  Catheter-associated thrombus + 159 Yes No
  SVT + 159 Yes No
 GI
  Recurrence of colitis +2756 Yes No
 Heme
  Lymphopenia +2249 No No
  Hypogammaglobulinemia + 1611 No No
 Secondary graft loss + 30 No No
Patient 2 (first transplantation)
 Infection
  S parasanguis bacteremia −2 Yes No
  CMV viremia + 19 Yes No
 Secondary graft loss + 33 No No
Patient 2 (second transplantation)
 Renal/GU
  Drug-associated nephropathy + 28 Yes No
 GvHD + 30 Yes No
Patient 3
 GvHD + 16 Yes No
Patient 4
 Heme
  Severe thrombocytopenia +5 Yes (+490) No
 Lymphopenia + 30 No no
 Hypogammaglobulinemia + 304 No No
 Secondary graft loss + 120 No No
 Death (sepsis, pneumonia) +779 No Yes
Patient 5
 Infection
  CMV Before transplantation No +7
  GvHD + 10 Yes No
 Death + 12
Patient 6 (first transplantation)
 Infection
  Fungal pneumonia + 24 Yes No
  BK virus reactivation + 24 No No
Patient 6 (second transplantation)
 Infection
  Adenovirus reactivation + 2 Yes No
  Cryptosporidium gut + 20 Yes No
  Fungal pneumonia + 74 No Yes
 GvHD + 17 Yes No
 Death +4 mo No Yes
Patient 7: Turkey
 Infection
  Mycotic aneurysm Before transplantation No Yes
 Bleeding + 88 No Yes
 Death +3 mo
Patient 8
 CV
  Cardiomyopathy + 1 No Yes
 Death +3
Patient 9 (first transplantation)
 Infection
  S mitis sepsis + 22 Yes No
 Hemophagocytosis +25 (first) No No
 Secondary graft loss +45 No Yes
Patient 9 (second transplantation)
 Infection + 14 No Yes
  Adenovirus viremia +35
 CV
  Cardiac/pleural effusion + 21 No Yes
 GI
  Ascites +21 No Yes
 Renal/GU
  Adenovirus cystitis +29 No No
 Secondary graft loss +32 No Yes
Patient 9 (third transplantation)
 Bleeding + 17 No Yes
 GI
  Pancreatitis + 13 Yes No
 Death + 109 No Yes
Patient 10: Japan
 CV
  TMA +20 Yes No
 Lung
  Acute pulmonary edema + 4 Yes No
 GI
  Recurrent pancreatitis −1, +32, +42, +53, +58, +63 Yes No
Patient 11
 Infection
  Pulmonary aspergillosis + 150 Yes No
 GI
  Hemorrhagic bleeding +30 Yes No
 Renal/GU
  Hemorrhagic cystitis + 18, +120 Yes No
 Heme
  Lymphopenia +50 Yes No
  Hypogammaglobulinemia +50
 GvHD
  Skin + 7 Yes No
  GI + 17 Yes No
Patient 12: Canada
 Lung
  Pulmonary hemorrhage +20 No Yes
 GI
  GI bleeding + 13 Yes No
 Renal/GU
  Renal failure +21 No Yes
 Other
  TEN + 16 No Yes
 GvHD + 12 No No
 Death +42 No Yes
Patient 13: United Kingdom
 GvHD +50 Yes No
Patient 14
 Infection
  CMV +31 Yes No
  Candidiasis +72 Yes No
  Sepsis +214 Yes No
 Secondary graft loss + 28, +90 No No
 Death (sepsis) +410 No Yes
Patient 15
 Infection
  Pneumonia +52, +300 Yes, no No, yes
GI
  Increased transaminase levels + 150 No No
Heme
  Severe thrombocytopenia + 150 No No
 Secondary graft loss + 130 No No
 Death +10 mo No Yes

CV, Cardiovascular; CVM. cytomegalovirus; GI, gastrointestinal; GU, genitourinary; SVT, supraventricular tachycardia; TEN, toxic epidermal necrolysis; TMA, thrombotic microangiopathy.